<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<jPostDataset id="JPST000361" formatVersion="1.0">
  <Project id="JPST000361" pxid="PXD008332" createdDate="2017-11-23" modifiedDate="2017-11-30" mode="partial" type="Mass spectrometry">
    <Title>Glioma initiating/stem cells, differentiation, iTRAQ analysis by QSTAR Elite</Title>
    <Description>Glioma initiating/stem cells (GIC/GSC) are considered responsible for the therapeutic resistance and recurrence of malignant glioma. To clarify the molecular mechanism of GIC/GSC maintenance/differentiation, we established GIC/GSC clones, having the potential to differentiate into malignant gliomas, from glioblastoma patientâ€™s tissues, and subjected to DNA microarray/iTRAQ based integrated proteomics. 21,857 mRNAs and 8,471 proteins were identified and integrated into a gene/protein expression analysis chart (iPEACH). The data integration and extraction of global proteins and mRNAs revealed that, during the GIC/GSC differentiation, cell adhesion molecules including integrin aV/ECMs and RAS-MAPK/PI3K signalings were significantly up-regulated, meanwhile, SOX2, CD133, and specific proteoglycans/synthetic-enzymes/metabolic pathways were obviously down-regulated. Among them, we focused proteoglycans and their synthetic-enzymes. GIC/GSC differentiation was significantly associated with the decrease of CSPG (CS-modified form) and dramatically induced by the CS-degradation enzyme which also induces the up-regulation of ERK-AKT signaling and GFAP without any other agents. Importantly, these differentiation processes were also associated with the interaction of CSPG (CS-unmodified form) and integrin-aV, and suppressed by integrin-inhibitors/CS administrations significantly. Combination treatments of a cancer-drug Temozolomide and these GIC/GSC-differentiation inhibitors suppressed glioma progression, increased the chemosensitivities, and led the longer survival of mouse xenograft-models. Functional integrated proteomics for the first time demonstrates that the GIC/GSC induces the specific proteoglycans to regulate GIC/GSC stemness/differentiation via the integlin signalings which may be a clinical target against malignant gliomas.</Description>
    <AnnouncementDate>2018-11-30</AnnouncementDate>
  </Project>
  <presetSummary>
    <Species>
      <PresetElement id="9606" value="Homo sapiens (Human)"/>
    </Species>
    <Instrument>
      <PresetElement id="MS:1000932" value="TripleTOF 5600"/>
    </Instrument>
    <Modification>
      <PresetElement id="MOD:01710" ontologyName="iTRAQ8plex reporter+balance reagent N-acylated residue" value="iTRAQ8plex (K)"/>
      <PresetElement id="MOD:01712" ontologyName="iTRAQ8plex reporter+balance reagent acylated N-terminal" value="iTRAQ8plex (N-term)"/>
      <PresetElement id="MOD:00719" ontologyName="L-methionine sulfoxide" value="Oxidation (M)"/>
      <PresetElement id="MOD:00110" ontologyName="L-cysteine methyl disulfide" value="Methylthio (C)"/>
    </Modification>
  </presetSummary>
  <Contact>
    <Name>Akiko Nambu</Name>
    <Affiliation>Kumamoto University</Affiliation>
    <PrincipalInvestigator>Norie Araki</PrincipalInvestigator>
  </Contact>
  <Relation>
    <Keywords>glioblastoma, glioma initiating/stem cell, cancer stem cells, differentiation</Keywords>
    <PubMed/>
  </Relation>
  <FileList>
    <File id="f_0000511593">
      <Name>Data110708_GSC-F4-2050v_2_120min-8.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511594">
      <Name>Data100930_GSC_D5_05-240min-9.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511595">
      <Name>Data100930_GSC_D5_025-240min-7.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511596">
      <Name>Data101011_GSC_D4_025-110min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511597">
      <Name>Data101011_GSC_D4_025-110min-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511598">
      <Name>Data101013_GSC_D4_025-110min-6.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511599">
      <Name>Data101015_GSC_D6_025-110min-5.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511600">
      <Name>Data101015_GSC_D6_025-110min-7.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511601">
      <Name>Data101016_GSC_D8-025_120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511602">
      <Name>Data101016_GSC_D8-025_-120min-4.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511603">
      <Name>Data101017_GSC_D3-025_120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511604">
      <Name>Data101017_GSC_D3-025_-120min-3.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511605">
      <Name>Data101018_GSC_D2-025-120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511606">
      <Name>Data101018_GSC_D2-025-120min-3.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511607">
      <Name>Data101018_GSC_D2-025-120min-4.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511608">
      <Name>Data101019_GSC_D7-025-120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511609">
      <Name>Data101019_GSC_D7-025-120min-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511610">
      <Name>Data101019_GSC_D7-025-120min-3.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511611">
      <Name>Data101019_GSC_D10_025-120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511612">
      <Name>Data101019_GSC_D10_025-2200V-120min-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511613">
      <Name>Data101019_GSC_D11_025-2200V-120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511614">
      <Name>Data101019_GSC_D11_025-2200V-120min-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511615">
      <Name>Data101020_GSC_D10_025-1850V-120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511616">
      <Name>Data101020_GSC_D10_025-1850V-120min-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511617">
      <Name>Data101020_GSC_D11_025-1850V-120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511618">
      <Name>Data101020_GSC_D11_025-1850V-120min-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511619">
      <Name>Data101021_GSC_D1-120min-2000V-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511620">
      <Name>Data101021_GSC_D1-120min-2000V-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511621">
      <Name>Data101021_GSC_E1-120min-2000V-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511622">
      <Name>Data101021_GSC_E1-120min-2000V-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511623">
      <Name>Data101023_GSC_D1_025-1800V-120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511624">
      <Name>Data101023_GSC_D1_025-1800V-120min-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511625">
      <Name>Data101023_GSC_E1_025-1800V-120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511626">
      <Name>Data101023_GSC_E1_025-1800V-120min-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511627">
      <Name>Data101024_GSC_E2-235min-1800V-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511628">
      <Name>Data101024_GSC_E2-235min-1800V-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511629">
      <Name>Data101024_GSC_E3-235min-1800V-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511630">
      <Name>Data101024_GSC_E3-235min-1800V-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511631">
      <Name>Data101028_GSC_E4-120min-2000V-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511632">
      <Name>Data101028_GSC_E4-120min-2000V-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511633">
      <Name>Data101105_GSC_E5-120min-2100V-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511634">
      <Name>Data101105_GSC_E5-120min-2100V-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511635">
      <Name>Data101105_GSC_E6-120min-2100V-3.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511636">
      <Name>Data101105_GSC_E6-120min-2100V-4.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511637">
      <Name>Data101114_GSC_E5-120min-2100V-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511638">
      <Name>Data101114_GSC_E5-120min-2100V-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511639">
      <Name>Data101114_GSC_E6-120min-2100V-3.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511640">
      <Name>Data101114_GSC_E6-120min-2100V-4.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511641">
      <Name>Data101116_GSC_E7-120min-2000V-6.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511642">
      <Name>Data101116_GSC_E7-120min-2000V-7.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511643">
      <Name>Data101116_GSC_F2-120min-2000V-4.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511644">
      <Name>Data101116_GSC_F2-120min-2000V-5.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511645">
      <Name>Data110214_GSC_E8-120min-1900V-x1-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511646">
      <Name>Data110214_GSC_E9-120min-1900V-x1-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511647">
      <Name>Data110704_GSC_E12_05-1800V-120min-5.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511648">
      <Name>Data110704_GSC_E13_05-1800V-120min-6.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511649">
      <Name>Data110704_GSC_E15_05-1800V-120min-7.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511650">
      <Name>Data110705_GSC_F14_05_1800V-120min-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511651">
      <Name>Data110705_GSC_F15_05_1800V-120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511652">
      <Name>Data110707_GSC_F5-2000V-120min-8.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511653">
      <Name>Data110707_GSC_F6-2000V-120min-7.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511654">
      <Name>Data110707_GSC_F7-2000V-120min-6.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511655">
      <Name>Data110707_GSC_F12-2000V-120min-4.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511656">
      <Name>Data110707_GSC_F13-2000V-120min-3.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511657">
      <Name>Data110708_ GSC_F10-2000V-120min-2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511658">
      <Name>Data110708_GSC_D9-2050v-120min-4.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511659">
      <Name>Data110708_GSC_F8-2050v-120min-7.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511660">
      <Name>Data110708_GSC_F9-2050v-120min-5.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511661">
      <Name>Data110708_GSC_F11-2000V-120min-1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511662">
      <Name>Data110708_GSC-D13-2050v_120min-11.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511663">
      <Name>Data110708_GSC-D14-2050v_2_120min-9.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511664">
      <Name>Data110708_GSC-F1-2050v_120min-13.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511665">
      <Name>Data110708_GSC-F3-2050v_120min-12.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511666">
      <Name>Data110708_GSC-F4-2050v_2_120min-8.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511667">
      <Name>Data100930_GSC_D5_05-240min-9.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511668">
      <Name>Data100930_GSC_D5_025-240min-7.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511669">
      <Name>Data101011_GSC_D4_025-110min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511670">
      <Name>Data101011_GSC_D4_025-110min-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511671">
      <Name>Data101013_GSC_D4_025-110min-6.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511672">
      <Name>Data101015_GSC_D6_025-110min-5.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511673">
      <Name>Data101015_GSC_D6_025-110min-7.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511674">
      <Name>Data101016_GSC_D8-025_120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511675">
      <Name>Data101016_GSC_D8-025_-120min-4.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511676">
      <Name>Data101017_GSC_D3-025_120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511677">
      <Name>Data101017_GSC_D3-025_-120min-3.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511678">
      <Name>Data101018_GSC_D2-025-120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511679">
      <Name>Data101018_GSC_D2-025-120min-3.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511680">
      <Name>Data101018_GSC_D2-025-120min-4.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511681">
      <Name>Data101019_GSC_D7-025-120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511682">
      <Name>Data101019_GSC_D7-025-120min-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511683">
      <Name>Data101019_GSC_D7-025-120min-3.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511684">
      <Name>Data101019_GSC_D10_025-120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511685">
      <Name>Data101019_GSC_D10_025-2200V-120min-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511686">
      <Name>Data101019_GSC_D11_025-2200V-120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511687">
      <Name>Data101019_GSC_D11_025-2200V-120min-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511688">
      <Name>Data101020_GSC_D10_025-1850V-120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511689">
      <Name>Data101020_GSC_D10_025-1850V-120min-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511690">
      <Name>Data101020_GSC_D11_025-1850V-120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511691">
      <Name>Data101020_GSC_D11_025-1850V-120min-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511692">
      <Name>Data101021_GSC_D1-120min-2000V-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511693">
      <Name>Data101021_GSC_D1-120min-2000V-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511694">
      <Name>Data101021_GSC_E1-120min-2000V-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511695">
      <Name>Data101021_GSC_E1-120min-2000V-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511696">
      <Name>Data101023_GSC_D1_025-1800V-120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511697">
      <Name>Data101023_GSC_D1_025-1800V-120min-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511698">
      <Name>Data101023_GSC_E1_025-1800V-120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511699">
      <Name>Data101023_GSC_E1_025-1800V-120min-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511700">
      <Name>Data101024_GSC_E2-235min-1800V-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511701">
      <Name>Data101024_GSC_E2-235min-1800V-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511702">
      <Name>Data101024_GSC_E3-235min-1800V-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511703">
      <Name>Data101024_GSC_E3-235min-1800V-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511704">
      <Name>Data101028_GSC_E4-120min-2000V-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511705">
      <Name>Data101028_GSC_E4-120min-2000V-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511706">
      <Name>Data101105_GSC_E5-120min-2100V-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511707">
      <Name>Data101105_GSC_E5-120min-2100V-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511708">
      <Name>Data101105_GSC_E6-120min-2100V-3.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511709">
      <Name>Data101105_GSC_E6-120min-2100V-4.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511710">
      <Name>Data101114_GSC_E5-120min-2100V-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511711">
      <Name>Data101114_GSC_E5-120min-2100V-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511712">
      <Name>Data101114_GSC_E6-120min-2100V-3.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511713">
      <Name>Data101114_GSC_E6-120min-2100V-4.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511714">
      <Name>Data101116_GSC_E7-120min-2000V-6.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511715">
      <Name>Data101116_GSC_E7-120min-2000V-7.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511716">
      <Name>Data101116_GSC_F2-120min-2000V-4.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511717">
      <Name>Data101116_GSC_F2-120min-2000V-5.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511718">
      <Name>Data110214_GSC_E8-120min-1900V-x1-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511719">
      <Name>Data110214_GSC_E9-120min-1900V-x1-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511720">
      <Name>Data110704_GSC_E12_05-1800V-120min-5.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511721">
      <Name>Data110704_GSC_E13_05-1800V-120min-6.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511722">
      <Name>Data110704_GSC_E15_05-1800V-120min-7.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511723">
      <Name>Data110705_GSC_F14_05_1800V-120min-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511724">
      <Name>Data110705_GSC_F15_05_1800V-120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511725">
      <Name>Data110707_GSC_F5-2000V-120min-8.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511726">
      <Name>Data110707_GSC_F6-2000V-120min-7.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511727">
      <Name>Data110707_GSC_F7-2000V-120min-6.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511728">
      <Name>Data110707_GSC_F12-2000V-120min-4.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511729">
      <Name>Data110707_GSC_F13-2000V-120min-3.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511730">
      <Name>Data110708_ GSC_F10-2000V-120min-2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511731">
      <Name>Data110708_GSC_D9-2050v-120min-4.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511732">
      <Name>Data110708_GSC_F8-2050v-120min-7.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511733">
      <Name>Data110708_GSC_F9-2050v-120min-5.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511734">
      <Name>Data110708_GSC_F11-2000V-120min-1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511735">
      <Name>Data110708_GSC-D13-2050v_120min-11.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511736">
      <Name>Data110708_GSC-D14-2050v_2_120min-9.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511737">
      <Name>Data110708_GSC-F1-2050v_120min-13.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511738">
      <Name>Data110708_GSC-F3-2050v_120min-12.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511739">
      <Name>Data100930_GSC_Elite-ALL-20161111.group</Name>
      <Type>result</Type>
      <Profile/>
      <Format>other</Format>
      <Software>ProteinPilot</Software>
    </File>
  </FileList>
  <AdditionalInformation/>
</jPostDataset>
